Abiopharma

BridgeBio Announces First Participant Dosed in ASCEND-ATTR, a Phase 3b/4 Study Evaluating the Long-Term Effects of Acoramidis on Disease Regression in ATTR-CM

Xeris Announces Details for XP-8121 Program Overview Webinar

Trevi Therapeutics Announces Upcoming Presentations at the European Respiratory Society (ERS) Congress 2026

Reklaim Ltd Reports Q2 2026 Results: Revenue Up 103%, Net Income of $723,000

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0000950103-26-012892 <b>Size:</b> 326 KB

New Form N-PX - BLACKROCK MUNIYIELD QUALITY FUND III, INC. <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001438934-26-001730 <b>Size:</b> 3 KB

New Form N-PX - BLACKROCK MUNIYIELD NEW YORK QUALITY FUND, INC. <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001438934-26-001729 <b>Size:</b> 3 KB

New Form N-PX - BLACKROCK INCOME TRUST, INC. <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001438934-26-001727 <b>Size:</b> 3 KB

New Form 424B2 - UBS AG <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001839882-26-041503 <b>Size:</b> 644 KB

Employee Stock Option/ Share Scheme: Grant of Share Awards

Nexera Technologies: Subsidiary Fort Technology Closes Acquisition of Majority Stake in Logia USA to Fuel the Future of Data Centers

New Form 424B2 - WELLS FARGO & COMPANY/MN <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001839882-26-041501 <b>Size:</b> 1 MB

New Form 424B2 - BANK OF NOVA SCOTIA <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001839882-26-041498 <b>Size:</b> 983 KB

New Form 425 - AEGON LTD. <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001193125-26-366139 <b>Size:</b> 56 KB

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0000950103-26-012891 <b>Size:</b> 319 KB